Literature DB >> 3056248

Antimalarial agents: specific treatment regimens.

D J Krogstad1, B L Herwaldt, P H Schlesinger.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3056248      PMCID： PMC172324          DOI： 10.1128/AAC.32.7.957

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  47 in total

Review 1.  Antimalarial agents: mechanism of chloroquine resistance.

Authors:  D J Krogstad; P H Schlesinger; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

2.  Malaria, anaemia and pregnancy.

Authors:  H M Gilles; J B Lawson; M Sibelas; A Voller; N Allan
Journal:  Ann Trop Med Parasitol       Date:  1969-06

3.  Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.

Authors:  D E Schwartz; E Weidekamm; I Mimica; P Heizmann; R Portmann
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

4.  Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity.

Authors:  Y Wattanagoon; R E Phillips; D A Warrell; K Silamut; S Looareesuwan; B Nagachinta; D J Back
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

5.  RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.

Authors:  S L Hoffman; D Rustama; A J Dimpudus; N H Punjabi; J R Campbell; H S Oetomo; H A Marwoto; S Harun; N Sukri; P Heizmann
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

6.  Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.

Authors:  D Garfinkel; R D Mamelok; T F Blaschke
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

7.  A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.

Authors:  J M Ekue; O O Simooya; U K Sheth; W H Wernsdorfer; E K Njelesani
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria.

Authors:  R E Phillips; D A Warrell; G Edwards; Y Galagedera; R D Theakston; D T Abeysekera; P Dissanayaka
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

Review 9.  Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.

Authors:  G D Overturf
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

Review 10.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728
View more
  6 in total

Review 1.  Antimalarial agents: specific chemoprophylaxis regimens.

Authors:  B L Herwaldt; D J Krogstad; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

2.  Tetracyclines as antiparasitic agents: lipophilic derivatives are highly active against Giardia lamblia in vitro.

Authors:  T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 4.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

5.  In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii.

Authors:  E Holfels; J McAuley; D Mack; W K Milhous; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

6.  Synthesis, SAR, and Docking Studies Disclose 2-Arylfuran-1,4-naphthoquinones as In Vitro Antiplasmodial Hits.

Authors:  Tatiane Freitas Borgati; Maria Fernanda Alves do Nascimento; Juma Fortunato Bernardino; Lunamaura Claudia Oliveira Martins; Alex Gutterres Taranto; Alaíde Braga de Oliveira
Journal:  J Trop Med       Date:  2017-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.